Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design (2013)
- Autores:
- Autores USP: TAQUEDA, MARIA ELENA SANTOS - EP ; BABY, ANDRÉ ROLIM - FCF ; KANEKO, TELMA MARY - FCF ; VELASCO, MARIA VALERIA ROBLES - FCF ; CONSIGLIERI, VLADI OLGA - FCF
- Unidades: EP; FCF
- DOI: 10.3109/10837450.2012.693508
- Assuntos: COMPRIMIDOS; CELULOSE; FÁRMACOS
- Agências de fomento:
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Pharmaceutical Development and Technology
- ISSN: 1083-7450
- Volume/Número/Paginação/Ano: v. 18, n. 5, p. 1247-1254, 2013
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DUQUE, Marcelo Dutra et al. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, v. 18, n. 5, p. 1247-1254, 2013Tradução . . Disponível em: https://doi.org/10.3109/10837450.2012.693508. Acesso em: 17 abr. 2024. -
APA
Duque, M. D., Kreidel, R. N., Taqueda, M. E. S., Baby, A. R., Kaneko, T. M., Velasco, M. V. R., & Consiglieri, V. O. (2013). Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, 18( 5), 1247-1254. doi:10.3109/10837450.2012.693508 -
NLM
Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2024 abr. 17 ] Available from: https://doi.org/10.3109/10837450.2012.693508 -
Vancouver
Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2024 abr. 17 ] Available from: https://doi.org/10.3109/10837450.2012.693508 - Influence of a bioactive substance on the physicochemical and functional stability of sunscreen emulsions
- Optimization of poorly compactable drug tablets manufactured by direct compression using the mixture experimental design
- Evaluation of hair damage treated with oxidative hair dye under influence of conditioners agents
- In vitro sun protection factor (spf) of commercial sunscreens by reflectance spectrophotometry
- Protein based nanotechnology: Antioxidant and photoprotection activities
- Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention
- Rutin increases critical wavelength of systems containing a single UV filter and with good skin compatibility
- Hydrating effects of moisturizer active compounds incorporated into hydrogels: in vivo assessment and comparison between devices
- Avaliação clínica in vitro da perda de água transepidérmica e comparação entre equipamentos
- Development and in vitro photoprotection efficacy of bioactive sunscreens containing rutin, avobenzone and octyl dimethyl paba
Informações sobre o DOI: 10.3109/10837450.2012.693508 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
